Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study
Richard P. McQuellon*, Howard T. Thaler, David Cella, David H. Moore
Dive into the research topics of 'Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.